Nicotine exposure through the use of electronic delivery systems (vaping) has been found to elevate the risk of certain conditions of the lungs (eg, vaping-associated lung injury). However, the potential impact of vaping on lung cancer risk remains largely unexplored. Lung Cancers Today spoke with Marisa Bittoni, PhD, of The Ohio State University Comprehensive Cancer Center, about the association between vaping and cigarette smoking and lung cancer risk in a case-control study conducted at The Ohio State University in Columbus. ...
Lung Cancers Today
A new medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and more.
Advertisement
Role of MicroRNAs on Anti-Apoptotic MCL-1/cIAP-2 Gene Expression in Patients With EGFR-Mutated NSCLC
A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer.
Patient-derived organoids have shown promise in modeling cancer therapy response.
A study that examined whether the combination of AI and knowledge can identify more patients with lung and ovarian cancers.
A study detailed the landscape of lung adenocarcinoma progression.
MK-1084 as monotherapy and in combination with pembrolizumab is effective in patients with NSCLC.
The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS.
The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS.
Lung cancer screening discussions are not happening as often as they could be among health care providers.
The postoperative comfort scale has good reliability and validity, and can be used to assess patients with lung cancer.
Just under a quarter of a million new cases of lung cancer were diagnosed in 2023, with 10-20% in non-smokers.
Advertisement
Expert Interviews on Lung Cancer
Conference Coverage
Our editors provide comprehensive coverage of ESMO Congress 2023, with a focus on lung cancer.
Our editors detail the latest data and innovations in the lung cancer space, as presented at WCLC 2023.
